Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.

about

Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.

Item

http://www.wikidata.org/entity/Q50145904

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@en

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@nl

type

Item

label

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@en

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@nl

prefLabel

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@en

Chromosomal abnormality variat ...... eated by R-CHOP-based therapy.

@nl

P1476

Chromosomal abnormality variat ...... reated by R-CHOP-based therapy

@en

P2093

Eri Kawata

http://www.w3.org/2001/XMLSchema#string

Hitoji Uchiyama

http://www.w3.org/2001/XMLSchema#string

Isao Yokota

http://www.w3.org/2001/XMLSchema#string

Kazuna Tanba

http://www.w3.org/2001/XMLSchema#string

Masafumi Taniwaki

http://www.w3.org/2001/XMLSchema#string

Mio Yamamoto-Sugitani

http://www.w3.org/2001/XMLSchema#string

Nobuhiko Uoshima

http://www.w3.org/2001/XMLSchema#string

Saeko Kuwahara-Ota

http://www.w3.org/2001/XMLSchema#string

Saori Maegawa

http://www.w3.org/2001/XMLSchema#string

Shigeo Horiike

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal instability and cancer: a complex relationship with therapeutic potential

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

Clonal evolution in hematological malignancies and therapeutic implications

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.

P304

655-664

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1342

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Junya Kuroda

P577

2018-02-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29473332

http://www.w3.org/2001/XMLSchema#string

P932

5852349

http://www.w3.org/2001/XMLSchema#string